Paediatrics research in Greater Manchester is overseen by the Greater Manchester, Lancashire & South Cumbria Medicines for Children Research Network (GMLC).
The network is led by Professor Peter Clayton (pictured right), who is a clinical academic at The University of Manchester and Honorary Consultant Paediatric Endocrinologist at the Royal Manchester Children's Hospital. Professor Clayton is also a member of the GM CLRN Executive Board with responsibility for tertiary care.
The NIHR CRN paediatric portfolio is split into the Medicines for Children Research Network (MCRN) portfolio (which is one of the topic specific networks) and also the Paediatric Specialty Group (PSG) portfolio which is part of the Comprehensive Research Network.
MCRN studies are medicinally orientated, with over 50% of the portfolio comprising of industry drug trials. The PSG portfolio focuses on studies which do not involve a medicine and tend to be more non interventional in nature.
The network has a large team of research staff based at the Royal Manchester Children's Hospital and also funds/supports part time paediatric research nurses at almost all District General Hospitals in the region.
We work closely with the Manchester Wellcome Trust Clinical Research Facility which has a dedicated paediatric clinical research facility in the Children's Hospital. The facility is suitable for early phase and/or inpatient MCRN clinical trials and is led by Dr Nick Webb, Deputy Director at GMLC.